We are delighted to announce the appointment of Dr. Linette Ruston as Senior Principal Scientist, ADME. Linette holds a BSc (Hons) and PhD in Chemistry from the Universities of Glasgow and Edinburgh, respectively. She is an experienced Biopharmaceutics and DMPK scientist having spent 17+ years with AstraZeneca where she held roles in Discovery and Early Pharmaceutical Development. Linette provided expert physicochemical, ADME and Biopharmaceutics input into compound design and selection, and applied knowledge of in vitro, in silico and in vivo models to enable material choice and project progression from discovery to early clinical development. Her current focus is on translation of DMPK/PD and biopharmaceutics understanding into meaningful product and clinical study design within Seda.
Linette will play a key role in provision of our DMPK consultancy which includes:
Seda’s DMPK consultancy offering recognises the vital importance of understanding the drug metabolism and pharmacokinetic (DMPK) properties of compounds to identify candidate molecules with suitable properties for development such as:
Please join us in welcoming Linette to the team.